Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer

Zhang, Sheng; Wei, Qing; Yang, Yongzhi; Qin, Huanlong; Li, Xinxiang; Cai, Sanjun; Ma, Yanlei

doi:10.7150/jca.28333



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2019; 10(3):689-696. doi:10.7150/jca.28333 This issue Cite

Research Paper

Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer

Sheng Zhang^1,2#, Qing Wei^3#, Yongzhi Yang^1,2, Huanlong Qin⁴, Xinxiang Li^1,2✉, Sanjun Cai^1,2✉, Yanlei Ma^1,2✉

1. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
3. Department of Pathology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China.
4. Department of GI Surgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
# Sheng Zhang and Qing Wei contributed equally to this work.

Citation:

Zhang S, Wei Q, Yang Y, Qin H, Li X, Cai S, Ma Y. Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer. J Cancer 2019; 10(3):689-696. doi:10.7150/jca.28333. https://www.jcancer.org/v10p0689.htm

Other styles

Abstract

Background: Yes-associated protein (YAP) is a downstream effecter of Hippo signaling pathway, and has been linked to the initiation and development of colorectal cancer (CRC). However, the clinical significance of YAP in CRC remains controversial. This study was designed to investigate the clinical significance of YAP in CRC.

Methods: We selected 206 eligible patients diagnosed with CRC from 2003 to 2007. Tissue microarray (TMA) blocks were made from 206 formalin-fixed paraffin-embedded CRC tissues and 158 corresponding normal colonic tissues. Using the TMA blocks, we performed immunohistochemical staining of YAP and assessed its expression status in different subcellular locations. The patients were divided into four groups according to the expression status of YAP in the cytoplasm and nucleus. Statistical analysis was performed to explore the correlation between YAP expression and clinicopathological features and overall survival (OS) in CRC patients.

Results: Our results showed that both cytoplasmic YAP and nuclear YAP were overexpressed in CRC tissues compared to normal colonic tissues. Complete loss of YAP expression in CRC was significantly correlated with larger tumor size (p=0.023), proximal tumor location (p=0.038), higher tumor grade (p=0.022) and worse OS (p<0.001). Univariate and multivariate Cox regression analyses revealed that complete loss of YAP expression was an independent indicator of poor prognosis in CRC (p<0.001).

Conclusions: Loss of YAP expression correlates with poor prognosis and may represent a subgroup with more aggressive biological features in CRC.

Keywords: Yes-associated protein, colorectal cancer, prognosis

Citation styles

APA

Zhang, S., Wei, Q., Yang, Y., Qin, H., Li, X., Cai, S., Ma, Y. (2019). Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer. Journal of Cancer, 10(3), 689-696. https://doi.org/10.7150/jca.28333.

ACS

Zhang, S.; Wei, Q.; Yang, Y.; Qin, H.; Li, X.; Cai, S.; Ma, Y. Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer. J. Cancer 2019, 10 (3), 689-696. DOI: 10.7150/jca.28333.

NLM

CSE

Zhang S, Wei Q, Yang Y, Qin H, Li X, Cai S, Ma Y. 2019. Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer. J Cancer. 10(3):689-696.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.